Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 63 articles:
HTML format
Text format



Single Articles


    October 2018
  1. MOU K, Ding M, Han D, Zhou Y, et al
    miR5905p inhibits tumor growth in malignant melanoma by suppressing YAP1 expression.
    Oncol Rep. 2018;40:2056-2066.
    PubMed     Text format     Abstract available


  2. PENG Y, Jia L, Wang S, Cao W, et al
    Sonodynamic therapy improves antitumor immune effect by increasing the infiltration of CD8+ T cells and altering tumor blood vessels in murine B16F10 melanoma xenograft.
    Oncol Rep. 2018;40:2163-2170.
    PubMed     Text format     Abstract available


    May 2018
  3. CHENG Q, Du J, Xie L, Liu X, et al
    Inhibition of SOX4 induces melanoma cell apoptosis via downregulation of NF-kappaB p65 signaling.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6443.
    PubMed     Text format     Abstract available


  4. WANG W, Li L, Chen F, Yang Y, et al
    Umbilical cordderived mesenchymal stem cells can inhibit the biological functions of melanoma A375 cells.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6446.
    PubMed     Text format     Abstract available


  5. GAGAT M, Krajewski A, Grzanka D, Grzanka A, et al
    Potential role of cyclin F mRNA expression in the survival of skin melanoma patients: Comprehensive analysis of the pathways altered due to cyclin F upregulation.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6435.
    PubMed     Text format     Abstract available


  6. RYABAYA O, Prokofieva A, Khochenkov D, Abramov I, et al
    Inhibition of endoplasmic reticulum stress-induced autophagy sensitizes melanoma cells to temozolomide treatment.
    Oncol Rep. 2018 May 9. doi: 10.3892/or.2018.6430.
    PubMed     Text format     Abstract available


  7. SI L, Yan X, Hao W, Ma X, et al
    Licochalcone D induces apoptosis and inhibits migration and invasion in human melanoma A375 cells.
    Oncol Rep. 2018;39:2160-2170.
    PubMed     Text format     Abstract available


    April 2018
  8. LI H, Chen J, Wang X, He M, et al
    Nodal induced by hypoxia exposure contributes to dacarbazine resistance and the maintenance of stemness in melanoma cancer stemlike cells.
    Oncol Rep. 2018 Apr 23. doi: 10.3892/or.2018.6387.
    PubMed     Text format     Abstract available


  9. WEI C, Lu N, Wang L, Zhang Y, et al
    Upregulation of UHRF1 promotes the progression of melanoma by inducing cell proliferation.
    Oncol Rep. 2018 Apr 4. doi: 10.3892/or.2018.6356.
    PubMed     Text format     Abstract available


    March 2018
  10. SUN MY, Wang Y, Zhu J, Lv C, et al
    Critical role for nonGAP function of Galphas in RGS1mediated promotion of melanoma progression through AKT and ERK phosphorylation.
    Oncol Rep. 2018 Mar 30. doi: 10.3892/or.2018.6341.
    PubMed     Text format     Abstract available


    February 2018
  11. WANG Q, Chen J, Wang A, Sun L, et al
    Differentially expressed circRNAs in melanocytes and melanoma cells and their effect on cell proliferation and invasion.
    Oncol Rep. 2018 Feb 13. doi: 10.3892/or.2018.6263.
    PubMed     Text format     Abstract available


    January 2018
  12. CHEN XEPSILON, Chen P, Chen SS, Ma T, et al
    miR106b5p promotes cell cycle progression of malignant melanoma by targeting PTEN.
    Oncol Rep. 2018;39:331-337.
    PubMed     Text format     Abstract available


    December 2017
  13. AKIYAMA Y, Kiyohara Y, Yoshikawa S, Otsuka M, et al
    Immune response-associated gene profiling in Japanese melanoma patients using multi-omics analysis.
    Oncol Rep. 2017 Dec 21. doi: 10.3892/or.2017.6173.
    PubMed     Text format     Abstract available


    November 2017
  14. KANG K, Zhang J, Zhang X, Chen Z, et al
    MicroRNA-326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways.
    Oncol Rep. 2017 Nov 2. doi: 10.3892/or.2017.6074.
    PubMed     Text format     Abstract available


    September 2017
  15. CORDARO FG, De Presbiteris AL, Camerlingo R, Mozzillo N, et al
    Phenotype characterization of human melanoma cells resistant to dabrafenib.
    Oncol Rep. 2017 Sep 18. doi: 10.3892/or.2017.5963.
    PubMed     Text format     Abstract available


    August 2017
  16. WANG DM, Jiao X, Plotnikoff NP, Griffin N, et al
    Killing effect of methionine enkephalin on melanoma in vivo and in vitro.
    Oncol Rep. 2017 Aug 24. doi: 10.3892/or.2017.5918.
    PubMed     Text format     Abstract available


  17. MONTI P, Ghiorzo P, Menichini P, Foggetti G, et al
    TP63 mutations are frequent in cutaneous melanoma, support UV etiology, but their role in melanomagenesis is unclear.
    Oncol Rep. 2017 Aug 14. doi: 10.3892/or.2017.5903.
    PubMed     Text format     Abstract available


    July 2017
  18. MENG F, Zhang Y, Li X, Wang J, et al
    Clinical significance of miR-138 in patients with malignant melanoma through targeting of PDK1 in the PI3K/AKT autophagy signaling pathway.
    Oncol Rep. 2017 Jul 19. doi: 10.3892/or.2017.5838.
    PubMed     Text format     Abstract available


    June 2017
  19. FENG R, Gong J, Wu L, Wang L, et al
    MAPK and Hippo signaling pathways crosstalk via the RAF-1/MST-2 interaction in malignant melanoma.
    Oncol Rep. 2017 Jun 30. doi: 10.3892/or.2017.5774.
    PubMed     Text format     Abstract available


  20. CHEN L, Cao Y, Rong D, Wang Y, et al
    MicroRNA-605 functions as a tumor suppressor by targeting INPP4B in melanoma.
    Oncol Rep. 2017 Jun 22. doi: 10.3892/or.2017.5740.
    PubMed     Text format     Abstract available


  21. QIU Z, Xing L, Zhang X, Qiang X, et al
    CpG oligodeoxynucleotides augment antitumor efficacy of folate receptor alpha based DNA vaccine.
    Oncol Rep. 2017;37:3441-3448.
    PubMed     Text format     Abstract available


    May 2017
  22. SHI J, Guo B, Hui Q, Chang P, et al
    Fangchinoline suppresses growth and metastasis of melanoma cells by inhibiting the phosphorylation of FAK.
    Oncol Rep. 2017 May 30. doi: 10.3892/or.2017.5678.
    PubMed     Text format     Abstract available


  23. XU X, Yokoyama S, Hayakawa Y, Saiki I, et al
    Coptidis Rhizoma induces intrinsic apoptosis through BAX and BAK activation in human melanoma.
    Oncol Rep. 2017 May 26. doi: 10.3892/or.2017.5672.
    PubMed     Text format     Abstract available


  24. AVRAM S, Coricovac DE, Pavel IZ, Pinzaru I, et al
    Standardization of A375 human melanoma models on chicken embryo chorioallantoic membrane and Balb/c nude mice.
    Oncol Rep. 2017 May 22. doi: 10.3892/or.2017.5658.
    PubMed     Text format     Abstract available


    April 2017
  25. ROOMI MW, Kalinovsky T, Niedzwiecki A, Rath M, et al
    Modulation of MMP-2 and -9 secretion by cytokines, inducers and inhibitors in human melanoma A-2058 cells.
    Oncol Rep. 2017 Apr 24. doi: 10.3892/or.2017.5597.
    PubMed     Text format     Abstract available


    March 2017
  26. BAI M, Zhang M, Long F, Yu N, et al
    Circulating microRNA-194 regulates human melanoma cells via PI3K/AKT/FoxO3a and p53/p21 signaling pathway.
    Oncol Rep. 2017 Mar 30. doi: 10.3892/or.2017.5537.
    PubMed     Text format     Abstract available


  27. SIPOS E, Hegyi K, Treszl A, Steiber Z, et al
    Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.
    Oncol Rep. 2017 Mar 8. doi: 10.3892/or.2017.5496.
    PubMed     Text format     Abstract available


  28. PERDUCA M, Dalle Carbonare L, Bovi M, Innamorati G, et al
    Runx2 downregulation, migration and proliferation inhibition in melanoma cells treated with BEL beta-trefoil.
    Oncol Rep. 2017 Mar 6. doi: 10.3892/or.2017.5493.
    PubMed     Text format     Abstract available


    February 2017
  29. ZHAO G, Han X, Cheng W, Ni J, et al
    Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5450.
    PubMed     Text format     Abstract available


    January 2017
  30. MADORSKY ROWDO FP, Baron A, von Euw EM, Mordoh J, et al
    In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells.
    Oncol Rep. 2017 Jan 13. doi: 10.3892/or.2017.5363.
    PubMed     Text format     Abstract available


  31. GUARNERI C, Bevelacqua V, Polesel J, Falzone L, et al
    NFkappaB inhibition is associated with OPN/MMP9 downregulation in cutaneous melanoma.
    Oncol Rep. 2017 Jan 10. doi: 10.3892/or.2017.5362.
    PubMed     Text format     Abstract available


    December 2016
  32. JIANG G, Li R, Tang J, Ma Y, et al
    Formulation of temozolomide-loaded nanoparticles and their targeting potential to melanoma cells.
    Oncol Rep. 2016 Dec 29. doi: 10.3892/or.2016.5342.
    PubMed     Text format     Abstract available


  33. PENG U, Wang Z, Pei S, Ou Y, et al
    ACY-1215 accelerates vemurafenib induced cell death of BRAF-mutant melanoma cells via induction of ER stress and inhibition of ERK activation.
    Oncol Rep. 2016 Dec 28. doi: 10.3892/or.2016.5340.
    PubMed     Text format     Abstract available


  34. LUO L, Cui J, Feng Z, Li Y, et al
    Lentiviral-mediated overexpression of KCTD12 inhibits the proliferation of human uveal melanoma OCM-1 cells.
    Oncol Rep. 2016 Dec 16. doi: 10.3892/or.2016.5325.
    PubMed     Text format     Abstract available


    November 2016
  35. GU Y, Wang J, Peng L
    (-)-Oleocanthal exerts anti-melanoma activities and inhibits STAT3 signaling pathway.
    Oncol Rep. 2016 Nov 23. doi: 10.3892/or.2016.5270.
    PubMed     Text format     Abstract available


  36. WANG E, Wang D, Li B, Ma H, et al
    Capn4 promotes epithelial-mesenchymal transition in human melanoma cells through activation of the Wnt/beta-catenin pathway.
    Oncol Rep. 2016 Nov 15. doi: 10.3892/or.2016.5247.
    PubMed     Text format     Abstract available


  37. LIU Y, Chu Z, Li Q, Peng B, et al
    Downregulation of Bmi-1 suppresses epithelialmesenchymal transition in melanoma.
    Oncol Rep. 2016 Nov 15. doi: 10.3892/or.2016.5244.
    PubMed     Text format     Abstract available


    October 2016
  38. OR CR, Su HL, Lee WC, Yang SY, et al
    Diphenhydramine induces melanoma cell apoptosis by suppressing STAT3/MCL-1 survival signaling and retards B16-F10 melanoma growth in vivo.
    Oncol Rep. 2016 Oct 25. doi: 10.3892/or.2016.5201.
    PubMed     Text format     Abstract available


  39. ZHANG D, Li Z, Zhang Y, Tu C, et al
    miR-4262 promotes the proliferation of human cutaneous malignant melanoma cells through KLF6-mediated EGFR inactivation and p21 upregulation.
    Oncol Rep. 2016 Oct 21. doi: 10.3892/or.2016.5190.
    PubMed     Text format     Abstract available


    September 2016
  40. CHEN J, Liu Y, Sun Q, Wang B, et al
    CYR61 suppresses growth of human malignant melanoma.
    Oncol Rep. 2016 Sep 23. doi: 10.3892/or.2016.5124.
    PubMed     Text format     Abstract available


  41. CHEN H, Zheng Z, Kim KY, Jin X, et al
    Hypermethylation and downregulation of glutathione peroxidase 3 are related to pathogenesis of melanoma.
    Oncol Rep. 2016 Sep 5. doi: 10.3892/or.2016.5071.
    PubMed     Text format     Abstract available


    August 2016
  42. ZHAO J, Zeng X, Song P, Wu X, et al
    AKT1 as the PageRank hub gene is associated with melanoma and its functional annotation is highly related to the estrogen signaling pathway that may regulate the growth of melanoma.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5048.
    PubMed     Text format     Abstract available


  43. HEO JR, Kim NH, Cho J, Choi KC, et al
    Current treatments for advanced melanoma and introduction of a promising novel gene therapy for melanoma (Review).
    Oncol Rep. 2016 Aug 24. doi: 10.3892/or.2016.5032.
    PubMed     Text format     Abstract available


  44. SHIH YL, Chou J, Yeh MY, Chou HM, et al
    Casticin induces DNA damage and inhibits DNA repair-associated protein expression in B16F10 mouse melanoma cancer cells.
    Oncol Rep. 2016 Aug 17. doi: 10.3892/or.2016.5027.
    PubMed     Text format     Abstract available


  45. GUO B, Hui Q, Zhang Y, Chang P, et al
    miR-194 is a negative regulator of GEF-H1 pathway in melanoma.
    Oncol Rep. 2016 Aug 12. doi: 10.3892/or.2016.5020.
    PubMed     Text format     Abstract available


    July 2016
  46. GAO Y, Gao W, Chen X, Cha N, et al
    Enhancing the treatment effect on melanoma by heat shock protein 70-peptide complexes purified from human melanoma cell lines.
    Oncol Rep. 2016 Jul 19. doi: 10.3892/or.2016.4947.
    PubMed     Text format     Abstract available


    June 2016
  47. WANG C, Xu W, Hao W, Wang B, et al
    Alternol inhibits the proliferation and induces the differentiation of the mouse melanoma B16F0 cell line.
    Oncol Rep. 2016 Jun 2. doi: 10.3892/or.2016.4844.
    PubMed     Text format     Abstract available


    May 2016
  48. SIM DY, Sohng JK, Jung HJ
    Anticancer activity of 7,8-dihydroxyflavone in melanoma cells via downregulation of alpha-MSH/cAMP/MITF pathway.
    Oncol Rep. 2016 May 20. doi: 10.3892/or.2016.4825.
    PubMed     Text format     Abstract available


  49. CHEN Y, Zhang Z, Luo C, Chen Z, et al
    MicroRNA-18b inhibits the growth of malignant melanoma via inhibition of HIF-1alpha-mediated glycolysis.
    Oncol Rep. 2016 May 20. doi: 10.3892/or.2016.4824.
    PubMed     Text format     Abstract available


    April 2016
  50. XU Z, Sun Y, Guo Y, Qin G, et al
    NF-YA promotes invasion and angiogenesis by upregulating EZH2-STAT3 signaling in human melanoma cells.
    Oncol Rep. 2016 Apr 20. doi: 10.3892/or.2016.4761.
    PubMed     Text format     Abstract available


    March 2016
  51. TANG Y, Cao K, Wang Q, Chen J, et al
    Silencing of CerS6 increases the invasion and glycolysis of melanoma WM35, WM451 and SK28 cell lines via increased GLUT1-induced downregulation of WNT5A.
    Oncol Rep. 2016 Mar 2. doi: 10.3892/or.2016.4646.
    PubMed     Text format     Abstract available


    February 2016
  52. ANDRE ND, Silva VA, Watanabe MA, De Lucca FL, et al
    Knockdown of chemokine receptor CXCR4 gene by RNA interference: Effects on the B16-F10 melanoma growth.
    Oncol Rep. 2016 Feb 12. doi: 10.3892/or.2016.4620.
    PubMed     Text format     Abstract available


  53. VENZA M, Visalli M, Catalano T, Biondo C, et al
    DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.
    Oncol Rep. 2016 Feb 11. doi: 10.3892/or.2016.4618.
    PubMed     Text format     Abstract available


  54. BANG W, Jeon YJ, Cho JH, Lee RH, et al
    beta-lapachone suppresses the proliferation of human malignant melanoma cells by targeting specificity protein 1.
    Oncol Rep. 2016;35:1109-1116.
    PubMed     Text format     Abstract available


  55. CHEN L, Liu T, Tu Y, Rong D, et al
    Cul1 promotes melanoma cell proliferation by promoting DEPTOR degradation and enhancing cap-dependent translation.
    Oncol Rep. 2016;35:1049-1056.
    PubMed     Text format     Abstract available


    November 2015
  56. ZHAO G, Han X, Zheng S, Li Z, et al
    Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells.
    Oncol Rep. 2015 Nov 12. doi: 10.3892/or.2015.4413.
    PubMed     Text format     Abstract available


  57. MI R, Pan C, Zhou Y, Liu Y, et al
    Identification of the metastasis potential and its associated genes in melanoma multinucleated giant cells using the PHA-ECM830 fusion method.
    Oncol Rep. 2015 Nov 2. doi: 10.3892/or.2015.4376.
    PubMed     Text format     Abstract available


    September 2015
  58. CHEN W, Jiang Z, Zhang X, Feng J, et al
    Nacetyl-S-(p-chlorophenylcarbamoyl)cysteine induces mitochondrial-mediated apoptosis and suppresses migration in melanoma cells.
    Oncol Rep. 2015 Sep 9. doi: 10.3892/or.2015.4267.
    PubMed     Text format     Abstract available


    July 2015
  59. YE Y, Chao XJ, Wu JF, Cheng BC, et al
    ERK/GSK3beta signaling is involved in atractylenolide I-induced apoptosis and cell cycle arrest in melanoma cells.
    Oncol Rep. 2015 Jul 6. doi: 10.3892/or.2015.4111.
    PubMed     Text format     Abstract available


    June 2015
  60. WANG Z, Li Z, Wang Y, Cao D, et al
    Versican silencing improves the antitumor efficacy of endostatin by alleviating its induced inflammatory and immunosuppressive changes in the tumor microenvironment.
    Oncol Rep. 2015;33:2981-91.
    PubMed     Text format     Abstract available


  61. AGOSTINI A, Panagopoulos I, Andersen HK, Johannesen LE, et al
    HMGA2 expression pattern and TERT mutations in tumors of the vulva.
    Oncol Rep. 2015;33:2675-80.
    PubMed     Text format     Abstract available


    May 2015
  62. CHEN R, Wang S, Yao Y, Zhou Y, et al
    Anti-metastatic effects of DNA vaccine encoding single-chain trimer composed of MHC I and vascular endothelial growth factor receptor 2 peptide.
    Oncol Rep. 2015;33:2269-76.
    PubMed     Text format     Abstract available


    April 2015
  63. HASHIMI SM, Xu T, Wei MQ
    Violacein anticancer activity is enhanced under hypoxia.
    Oncol Rep. 2015;33:1731-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: